What do systematic reviews say?

Summary of findings 2: Immunotherapies vs placebo

• Adverse effects of immunotherapies for multiple sclerosis: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 1421 participants
  Very low
• Adverse effects of immunotherapies for multiple sclerosis: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 1421 participants
  Low

Summary of findings 2: Immunotherapies vs placebo

• Adverse effects of immunotherapies for multiple sclerosis: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 1948 participants
  Very low

Summary of findings 2: Immunotherapies vs placebo

• Adverse effects of immunotherapies for multiple sclerosis: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 31 participants
  Very low

Summary of findings 2: Immunotherapies vs placebo

• Adverse effects of immunotherapies for multiple sclerosis: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  13 studies · 4007 participants
  Very low

Summary of findings 2: Immunotherapies vs placebo

• Adverse effects of immunotherapies for multiple sclerosis: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 1336 participants
  Very low
• Adverse effects of immunotherapies for multiple sclerosis: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 1336 participants
  Low

Summary of findings 2: Immunotherapies vs placebo

• Adverse effects of immunotherapies for multiple sclerosis: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  15 studies · 4752 participants
  Low

Summary of findings 2: Immunotherapies vs placebo

• Adverse effects of immunotherapies for multiple sclerosis: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  7 studies · 533 participants
  Very low

Summary of findings 2: Immunotherapies vs placebo

• Adverse effects of immunotherapies for multiple sclerosis: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 182 participants
  Very low

Summary of findings 2: Immunotherapies vs placebo

• Adverse effects of immunotherapies for multiple sclerosis: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  16 studies · 3886 participants
  Low

Summary of findings 2: Immunotherapies vs placebo

• Adverse effects of immunotherapies for multiple sclerosis: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  12 studies · 3615 participants
  Low

Summary of findings 2: Immunotherapies vs placebo

• Adverse effects of immunotherapies for multiple sclerosis: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  13 studies · 4688 participants
  Low

Summary of findings 2: Immunotherapies vs placebo

• Adverse effects of immunotherapies for multiple sclerosis: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 369 participants
  Very low

Summary of findings 2: Immunotherapies vs placebo

• Adverse effects of immunotherapies for multiple sclerosis: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 2674 participants
  Low

Summary of findings 2: Immunotherapies vs placebo

• Adverse effects of immunotherapies for multiple sclerosis: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  17 studies · 3692 participants
  Low

Summary of findings table ‐ Mental Health First Aid (MHFA) training vs alternative mental health literacy interventions

The review found no eligible studies for this question.

• Mental Health First Aid as a tool for improving mental health and well‐being 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Mental Health First Aid (MHFA) training vs alternative mental health literacy interventions

The review found no eligible studies for this question.

• Mental Health First Aid as a tool for improving mental health and well‐being 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Mental Health First Aid (MHFA) training vs alternative mental health literacy interventions

The review found no eligible studies for this question.

• Mental Health First Aid as a tool for improving mental health and well‐being 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Mental Health First Aid (MHFA) training vs alternative interventions

The review found no eligible studies for this question.

• Mental Health First Aid as a tool for improving mental health and well‐being 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Mental Health First Aid (MHFA) training vs alternative interventions

The review found no eligible studies for this question.

• Mental Health First Aid as a tool for improving mental health and well‐being 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Mental Health First Aid (MHFA) training vs alternative interventions

The review found no eligible studies for this question.

• Mental Health First Aid as a tool for improving mental health and well‐being 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found